Literature DB >> 9217137

Treatment of ventricular dysphonia with botulinum toxin.

K A Kendall1, R J Leonard.   

Abstract

Ventricular dysphonia, traditionally known as dysphonia plica ventricularis, is a voicing disorder in which the false vocal folds are used as a vibratory source in addition to or instead of the true vocal folds. Traditional treatment of ventricular dysphonia has been voice therapy, which may be slow to produce results if the false fold activity masks an underlying problem of the true folds, is long standing, or has produced hypertrophy of the supraglottic structures. We present seven cases of ventricular dysphonia treated with botulinum toxin injection into the false vocal folds followed by speech therapy. The addition of botulinum toxin to the treatment regimen speeds recovery of normal voicing and allows immediate evaluation of dynamic true vocal fold function by the treating professional.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217137     DOI: 10.1097/00005537-199707000-00022

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  [The application of botulinum toxin in oromandibular, pharyngeal and laryngeal dystonia].

Authors:  A Olthoff; R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Viscoelastic properties of human aryepiglottic fold and ventricular fold tissues at phonatory frequencies.

Authors:  Miwako Kimura; Roger W Chan
Journal:  Laryngoscope       Date:  2017-12-15       Impact factor: 3.325

Review 3.  Chemodenervation of the Larynx.

Authors:  Rachel Kaye; Andrew Blitzer
Journal:  Toxins (Basel)       Date:  2017-11-02       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.